Neovacs SA (0LW1) Income Statement
Neovacs SA Income Statement
Last quarter (Q4 2025), Neovacs SA's total revenue was $71.05K, an increase of 73.10% from the same quarter last year. In Q4, Neovacs SA's net income was $-2.46M. See Neovacs SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 23 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 161.78K | $ 533.41K | $ 366.35K | $ 1.11K | $ 22.59K | |
| $ -4.52M | $ -6.75M | $ 42.42K | $ -6.26M | $ -7.60M | |
| $ 903.13K | $ 153.19K | $ 6.66M | $ 183.98K | $ 242.98K | |
| Depreciation and Amortization | $ 185.70K | $ 163.91K | $ 6.94M | $ 151.29K | $ 99.37K |
| $ -5.24M | $ -8.45M | $ -6.61M | $ -3.61M | $ -10.38M | |
| $ -5.43M | $ -6.91M | $ -6.76M | $ -6.44M | $ -7.84M | |
| $ -98.17K | $ -2.71M | $ -27.33M | $ 2.10M | $ -4.64M | |
| $ -5.53M | $ -9.62M | $ -33.95M | $ -4.35M | $ -12.48M | |
| $ -4.90M | $ -8.74M | $ -32.91M | $ -3.55M | $ -11.84M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.13 | $ -2490000.00 | $ -1886061.00 | $ -11760.00 | $ -47200000000000.00 |
| Diluted EPS | $ -0.13 | $ -2490000.00 | $ -1886061.00 | $ -11760.00 | $ -47200000000000.00 |
| Weighted Average Shares Outstanding | 37.45M | 0 | 17 | 0 | 0 |
| Weighted Average Shares Outstanding (Diluted) | 37.45M | 0 | 17 | 0 | 0 |
Currency in EUR